Cadence Capital Management’s Sharps Compliance Corp SMED Stock Holding History

Cadence Capital Management’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$252K	Sell	40,184 -131,571	-77%	-$957K	0.06%	255
2020 Q2	$1.21M	Buy	171,755 +7,165	+4%	+$50.9K	0.18%	186
2020 Q1	$1.31M	Buy	+164,590	New	+$848K	0.22%	138
2018 Q3	–	Sell	-231,134	Closed	-$853K	–	726
2018 Q2	$853K	Buy	231,134 +10,909	+5%	+$43K	0.05%	416
2018 Q1	$1M	Buy	220,225 +281	+0.1%	+$1.26K	0.07%	398
2017 Q4	$900K	Buy	219,944 +18,422	+9%	+$77.4K	0.06%	399
2017 Q3	$963K	Buy	201,522 +24,072	+14%	+$116K	0.06%	393
2017 Q2	$751K	Buy	177,450 +8,860	+5%	+$37.8K	0.05%	424
2017 Q1	$802K	Buy	168,590 +6,710	+4%	+$30.8K	0.06%	401
2016 Q4	$620K	Sell	161,880 -5,594	-3%	-$22.7K	0.04%	459
2016 Q3	$734K	Buy	167,474 +58,518	+54%	+$284K	0.05%	399
2016 Q2	$478K	Sell	108,956 -2,031	-2%	-$9.61K	0.04%	456
2016 Q1	$610K	Hold	110,987	–	–	0.04%	428
2015 Q4	$966K	Buy	110,987 +14,460	+15%	+$125K	0.06%	302
2015 Q3	$846K	Sell	96,527 -71,379	-43%	-$516K	0.06%	336
2015 Q2	$1.17M	Sell	167,906 -4,816	-3%	-$30.2K	0.07%	380
2015 Q1	$1.1M	Buy	172,722 +1,590	+0.9%	+$8.04K	0.07%	390
2014 Q4	$729K	Buy	171,132 +10,317	+6%	+$45.8K	0.04%	459
2014 Q3	$703K	Sell	160,815 -4,430	-3%	-$19.9K	0.04%	456
2014 Q2	$727K	Sell	165,245 -18,202	-10%	-$75.2K	0.03%	447
2014 Q1	$840K	Buy	183,447 +94,907	+107%	+$447K	0.04%	460
2013 Q4	$419K	Buy	+88,540	New	+$375K	0.02%	550

Other funds holding SMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cadence Capital Management's SMED Position: Q3 2020 in Review

Cadence Capital Management reduced its Sharps Compliance Corp (SMED) stake by 77% in Q3 2020, selling an estimated $957K and leaving 40,184 shares worth $252K. The position accounts for 0.06% of the portfolio, ranked #255.

Cadence Capital Management first reported a position in SMED in Q4 2013 and has held it in 22 quarters since. The position peaked at $1.31M in Q1 2020. 68 funds tracked by Wall St. Rank hold SMED as of Q3 2020.

Cadence Capital Management held 40,184 shares of Sharps Compliance Corp worth $252K as of Q3 2020.
Cadence Capital Management sold 131,571 Sharps Compliance Corp shares in Q3 2020, an estimated $957K.
Sharps Compliance Corp made up 0.06% of Cadence Capital Management's portfolio in Q3 2020, its #255 holding.
Cadence Capital Management first reported a position in Sharps Compliance Corp in Q4 2013 and has held it in 22 quarters since.
Cadence Capital Management's Sharps Compliance Corp position peaked at $1.31M in Q1 2020.
68 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.